Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
Ng
Y-Y
YY
Yang
W-C
WC
Lee
S-T
ST
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004279:DNA, Viral / Q000235:genetics; D024882:Drug Resistance, Viral / Q000235:genetics; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000821:virology*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D009154:Mutation; D012074:Remission Induction; D013997:Time Factors
D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine